Jakse G
Eur Urol. 1981;7(2):68-72. doi: 10.1159/000473182.
In two subsequent, non-randomized groups of 9 patients with carcinoma in situ doxorubicin hydrochloride was applied intravesically. The dosage used was 40 and 80 mg. Tumour remission was obtained in 6 patients per group. The tumour grade might be of prognostic value. Cold cup random biopsies are warranted in the follow-up.
在随后的两组各9例原位癌患者中，对其膀胱内灌注盐酸阿霉素。使用的剂量分别为40毫克和80毫克。每组有6例患者肿瘤缓解。肿瘤分级可能具有预后价值。随访中需进行冷杯随机活检。
